Healthcare Companies' Annual Reports & Investor Relations Material

1067 Companies

OPTN

OptiNose, Inc.

OptiNose, Inc. is a pharmaceutical company with a keen focus on developing and commercializing products exclusively for patients receiving treatment by ear, nose, throat, and allergy specialists in...

OptiNose, Inc. Annual Report 2023

Healthcare Drug Manufacturers - Other NASDAQ 201-500

ABMD

Abiomed

Abiomed is a global leader in healthcare technology and innovation, with a focus on developing groundbreaking technologies to assist or replace the life-sustaining pumping function of the failing h...

Abiomed Annual Report 2020

Healthcare Medical Appliances & Equipment NASDAQ 1001-5000

INO

Inovio Pharmaceuticals

Inovio Pharmaceuticals, Inc. is a leading biotechnology company that specializes in the development of DNA medicines that treat and safeguard individuals from diseases associated with human papillo...

Inovio Pharmaceuticals Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

MBRX

Moleculin Biotech, Inc.

Houston-based pharmaceutical company Moleculin Biotech, Inc. is making strides in the development of drug candidates for the treatment of cancers and viruses. Its Annamycin drug candidate is curren...

Moleculin Biotech, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

NOVN

Novan

Durham-based medical dermatology company, Novan, Inc., is actively focused on developing and commercializing therapeutic products to combat various skin diseases. With a range of clinical stage der...

Novan Annual Report 2021

Healthcare Biotechnology NASDAQ 11-50

ITGR

Integer

Integer Holdings Corporation, a medical device outsource manufacturer, operates in several countries including the United States, Puerto Rico, and Costa Rica. The company, which operates through Me...

Integer Annual Report 2023

Healthcare Medical Appliances & Equipment NYSE 5001-10,000

AXSM

Axsome Therapeutics

Axsome Therapeutics Inc., a US-based biopharmaceutical firm, is dedicated to the creation of innovative treatments for central nervous system (CNS) disorders. The company has a strong commercial pr...

Axsome Therapeutics Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

VSTM

Verastem Oncology

Development-stage biopharmaceutical company Verastem, Inc. is at the forefront of cancer treatment drug development and commercialization. Among its promising products in development is VS-6766, a ...

Verastem Oncology Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

BGT

Bio-Gene Technology Limited

BlackRock Inc. has recently launched their BlackRock Floating Rate Income Trust, which operates as a close-ended fixed income mutual fund. The fund, which is administered by BlackRock Advisors, LLC...

Bio-Gene Technology Limited Annual Report 2023

Healthcare Biotechnology ASX 1-10

WST

West Pharmaceutical Services

West Pharmaceutical Services, Inc. is a leading provider of containment and delivery systems for injectable drugs and healthcare products across the Americas, Europe, the Middle East, Africa, and t...

West Pharmaceutical Services Annual Report 2023

Healthcare Medical Instruments & Supplies NYSE 10,000+

RVP

Retractable Technologies, Inc.

Retractable Technologies, Inc: Designs, Develops and Markets Safety Medical Products Globally Little Elm, Texas-based Retractable Technologies, Inc. (NYSE American: RVP) is a leader in the design,...

Retractable Technologies, Inc. Annual Report 2023

Healthcare Medical Instruments & Supplies NYSE 51-200

SBTX

SkinBioTherapeutics

SkinBioTherapeutics is a promising life science company that strives to enhance skin health through its unique platform technology, SkinBiotix®. This proprietary technology is the result of extensi...

SkinBioTherapeutics Annual Report 2023

Healthcare Biotechnology LSE 1-10

SRNE

Sorrento Therapeutics

Sorrento Therapeutics is making strides in its development of new treatments for cancer, inflammation, and autoimmune diseases. The California-based biopharmaceutical company is focused on antibodi...

Sorrento Therapeutics Annual Report 2021

Healthcare Biotechnology NASDAQ 51-200

CABA

Cabaletta Bio, Inc.

Cabaletta Bio, a biotech startup headquartered in Philadelphia, is making waves with their cutting-edge work on engineered T cell therapies to treat B cell-mediated autoimmune diseases. Currently, ...

Cabaletta Bio, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

FLGT

Fulgent Genetics

Fulgent Genetics, Inc. is a leading provider of clinical diagnostic and therapeutic development solutions for patients and physicians around the globe. The company boasts an impressive portfolio of...

Fulgent Genetics Annual Report 2023

Healthcare Diagnostic Substances NASDAQ 51-200